U.S. Markets for Respiratory Care Products, March 2014

In the United States (U.S.), more than 35 million people suffer from some form of respiratory disorder and 1 in 6 deaths are caused by chronic lung disease.  According to the American Lung Association, the annual economic burden of lung disease in the U.S. is estimated at $154 billion, consisting of $95 billion in direct healthcare costs and $59 billion in indirect costs including lost work days.  

This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for respiratory care products.  Product areas covered by the scope of this report include ventilator systems (including adult/pediatric, neonatal, and transport ventilators), blood gas monitoring systems (including point-of-care blood gas analyzers, pulse oximetry products, capnography monitoring products, laboratory blood gas analyzers, arterial blood gas sampling kits, and oxygen monitoring products), pulmonary function assessment products (including diagnostic spirometry products, pulmonary function testing products, and pulmonary exercise testing/metabolic assessment products), sleep apnea management products (including obstructive sleep apnea therapy products, polysomnography products, and obstructive sleep apnea monitoring products), and airway management accessories (including nebulizer compressors, small-volume nebulizers, heat/moisture exchangers, respiratory masks, humidifiers, and large-volume nebulizers).  

During the forecast period covered by this report, the combined U.S. market for respiratory care products is projected to increase from $3.8 billion in 2013 to $5.4 billion in the year 2018.  The segment that is expected to experience the greatest growth is represented by sales of sleep apnea management products with 8.3%, followed by airway management accessories with 6.2%, blood gas monitoring products with 5.7%, pulmonary function assessment products with 5.5%, and ventilator systems with 5.3%.